RecallDepth
Class II Terminated

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

This recall has been terminated (originally issued March 8, 2023).

Company
The Harvard Drug Group
Recall Initiated
February 23, 2023
Posted
March 8, 2023
Recall Number
D-0432-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
17,586 cartons
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot: M04145 Exp. 01/2024

More recalls by The Harvard Drug Group

View all recalls by this company →

Other recent Class II Drug recalls